Unmet Needs in Managing Atopic Dermatitis
Elizabeth A. Swanson, MD, and Raj. J. Chovatiya, MD, PhD, examine challenges in managing atopic dermatitis and explore the evolving treatment landscape.
Key Takeaways for Atopic Dermatitis Management
Korey Capozza, MPH; Elizabeth A. Swanson, MD; and Taylor Capps share pearls for patients and their families managing atopic dermatitis.
Patient Advocacy for Atopic Dermatitis
Korey Capozza, MPH, highlights the importance of patient advocacy in the atopic dermatitis journey.
Barriers to Access for Atopic Dermatitis Therapies
Raj J. Chovatiya, MD, PhD; Elizabeth A. Swanson, MD; Tina Capps; and Taylor Capps assess barriers in finding and obtaining atopic dermatitis treatments.
Role of Disease-Modifying Therapies for Atopic Dermatitis Treatment
Elizabeth A. Swanson, MD, discusses the safety and efficacy of dupilumab in treating moderate to severe atopic dermatitis, and Taylor Capps shares her journey with dupilumab from insurance approvals through receiving treatment.
Pharmacologic Treatment Options for Atopic Dermatitis
Raj J. Chovatiya, MD, PhD, reviews goals of therapy for patients with atopic dermatitis and comments on the use of various topical therapies and systemic agents for disease management.
Using Multidisciplinary Care to Optimize Atopic Dermatitis Treatment
Korey Capozza, MPH, examines the role of multidisciplinary care for patients with atopic dermatitis, and Taylor Capps shares the impact of atopic dermatitis on mental health.
Patient Selection for Atopic Dermatitis Therapies
Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.
Approaching the Management of Atopic Dermatitis
Raj J. Chovatiya, MD, PhD, discusses the level of awareness of atopic dermatitis within the medical community and approaching the management of disease.
The Effect of Atopic Dermatitis on Pediatric and Adult Patients
Elizabeth A. Swanson, MD, describes the burden of atopic dermatitis on the pediatric and adult patient populations.
Clinical Presentation of Atopic Dermatitis
Raj J. Chovatiya, MD, PhD, reviews the clinical manifestations and underdiagnoses of atopic dermatitis.
Addressing Lack of Atopic Dermatitis Education
Korey Capozza, MPH, offers insight into changing public perception of atopic dermatitis and bridging unmet needs in the field.
Impact of Atopic Dermatitis on QoL
Taylor and Tina Capps assess the burden of atopic dermatitis on Taylor’s life and the impact on her family.
Patient Diagnosis and Early Treatment of Atopic Dermatitis
Taylor and Tina Capps comment on Taylor’s experience of treatment regimens early on and the impact of underlying medical conditions on her atopic dermatitis.
Patient Presentation of Atopic Dermatitis
Taylor Capps and her mother, Tina Capps, share Taylor’s initial journey with atopic dermatitis and presenting symptoms.
Atopic Dermatitis: An Evolving Treatment Landscape
Closing out its discussion on atopic dermatitis, the panel considers best practices and unmet needs in the treatment landscape.
When to Change Therapy for Atopic Dermatitis
A brief discussion on when it is best to switch therapy while treating patients for atopic dermatitis.
Atopic Dermatitis: Systemic Therapy Armamentarium
Shared insight on the armamentarium of systemic agents available to treat atopic dermatitis.
Topical Calcineurin and PDE-4 Inhibitors in the Treatment of AD
A review of topical therapies that have been long utilized for patients with atopic dermatitis.
Atopic Dermatitis: Patient Factors in Selecting Therapy
A brief review of patient and disease factors that inform selection of therapy for atopic dermatitis.
Nonpharmacological Approaches to Managing Atopic Dermatitis
Expert insight on nonpharmacological strategies to treat atopic dermatitis and improve patient quality of life.
Concomitant Use of JAK Inhibitors in Atopic Dermatitis
A brief evaluation of the concomitant use of JAK inhibitors, topical or systemic, in patients with atopic dermatitis.
Systemic JAK Inhibition in Atopic Dermatitis Care Strategies
Switching its focus to systemic JAK inhibitors, the panel reviews real-world use of available agents to treat patients with atopic dermatitis.
Topical JAK Inhibition in Atopic Dermatitis Care Strategies
The panelists discuss real-world use of topical ruxolitinib in atopic dermatitis management given safety, efficacy, and availability.
Atopic Dermatitis: Clinical Trials With Topical Ruxolitinib
Considerations for topical ruxolitinib with deference to positive clinical trial results in atopic dermatitis.
An Overview of JAK Inhibition in Atopic Dermatitis
Shared insight on the available JAK inhibitors for atopic dermatitis, both topical and systemic.
Identifying Comorbidities Associated With Atopic Dermatitis
Experts reflect on the various comorbid conditions associated with atopic dermatitis and how they can affect patients.
What is the Burden of Atopic Dermatitis?
Comprehensive discussion on how atopic dermatitis can impact a patient’s quality of life.
Persistent Atopic Dermatitis and Flare-ups
Considerations for persistent atopic dermatitis vs outgrowing disease, followed by triggers that can result in flare-ups.
Understanding Patient Presentations With Atopic Dermatitis
Shared insight on the ways a child or adult may present with atopic dermatitis.
2 Clarke Drive Cranbury, NJ 08512